Allergan PLC (AGN)

• Annual Data
• Quarterly Data

Allergan PLC, Common-Size Consolidated Statement of Financial Position, Assets

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Cash and cash equivalents
	Short-term investments
	Teva shares
	Marketable securities
	Accounts receivable, net
	Inventories
	Current assets held for sale
	Prepaid taxes
	Prepaid insurance
	Royalty receivables
	Sales and marketing
	Other
	Prepaid expenses and other current assets
	Deferred tax assets
	Current assets
	Property, plant and equipment, net
	Deferred executive compensation investments
	Equity method investments
	Cost method investments
	Other long-term investments
	Taxes receivable
	Contingent income
	Other assets
	Investments and other assets
	Non current assets held for sale
	Deferred tax assets
	Product rights and other intangibles
	Goodwill
	Non current assets
	Total assets

Based on: 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-24), 10-K (filing date: 2016-02-26), 10-K (filing date: 2015-02-18).